Access to this full-text is provided by Springer Nature.
Content available from BMC Urology
This content is subject to copyright. Terms and conditions apply.
Lietal. BMC Urol (2021) 21:63
https://doi.org/10.1186/s12894-021-00833-4
RESEARCH ARTICLE
Tubularized urethral reconstruction using
everted saphenous vein graft inabeagle model
Dan Li1, Zhou Shen2 and Yujie Xu3*
Abstract
Background: A long segment stricture in the anterior urethra is a challenge in urology. We conducted a study to
investigate the efficacy of anterior urethral reconstruction using an everted saphenous vein graft (SVG) in a tubular
fashion.
Methods: Twelve male beagles were randomly divided into three groups: experimental group (n = 5), control group
(n = 5) and normal group (n = 2). A 3 cm defect in the anterior urethra was created. Autologous SVG was harvested.
In the experimental group, urethral defect was replaced by an everted SVG in a tubular fashion. In the control group,
urethral reconstruction was performed using an uneverted SVG. Beagles in all groups received retrograde urethrogra-
phy to evaluate urethral patency and were killed for histological examination 6 months after operation.
Results: Four beagles in the experimental group had no voiding difficulty and the other one could not void sponta-
neously. Retrograde urethrography showed the four beagles in experimental group had wide urethral lumens. Ether
urethral stricture or fistula were detected in all animals in the control group. Histological analysis of the four beagles in
the experimental group indicated the everted SVG completely integrated into the urethra. The reconstructed urethra
contained a wide lumen and was completely covered by urothelium. The periurethral collagen and muscle fibers
formed and were highly organized. Everted SVG showed a high ability of neovascularization. In the control group, the
reconstructed segment showed a fibrotic urethral lumen where the urothelium was not intact. Only few new capillar-
ies were formed.
Conclusions: Everted SVG demonstrates for a promising strategy for potential urethral stricture repair.
Keywords: Urethral stricture, Saphenous vein graft, Urethral reconstruction, Tubularized urethroplasty
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Adult and pediatric disorders of the urethra including
hypospadias, trauma, and stricture require substituted
urethroplasty to preserve the function of the urinary
tract. Reconstruction of the anterior urethra is one of the
most challenging problems in urology [1].
Autologous tissues have advantages of excellent bio-
logical compatibility as well as rapid and effective
neovascularization. Oral mucosa and penile skin flap are
preferred substituted materials for urethral reconstruc-
tion [2, 3]. Onlay urethroplasty and multi-stage repair
are commonly used techniques [4]. In some cases, these
methods have problems including stricture recurrence,
fistula formation and inadequate donor material. Har-
vesting oral mucosa is associated with donor site mor-
bidity, such as submucosal scarring, pain, numbness and
injury to salivary ducts [5, 6]. ese issues highlight a
critical need for the development of alternative material
and reconstructive strategies for anterior urethral repair.
e saphenous vein is commonly used as vascular
substitute material. It is easily harvested, and its associ-
ated wound complications were not dramatic, including
Open Access
*Correspondence: xyj_1213@126.com
3 Department of Urology, The First Affiliated Hospital of Wannan Medical
College (Yijishan Hospital of Wannan Medical College), 2 Zheshan West
Road, Wuhu 241000, Anhui Province, China
Full list of author information is available at the end of the article
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Page 2 of 6
Lietal. BMC Urol (2021) 21:63
chronic pain, numbnes and paresthesia/dysesthesia [7].
We previously performed urethroplasty in a rabbit model
using everted SVG as an onlay graft and gained encour-
aging results [8]. e inner wall of blood vessels consist
of vascular endothelium. We hypothesized that everting
vein graft makes the outside vascular endothelium cling
to periurethral tissue. In turn, the endothelium quickly
attracts blood supply from the surrounding periurethral
tissues including dartos. Here, we compare differences
in neovascularization between everted SVG and non-
everted SVG.
In addition, saphenous vein has a similar caliber as
the urethra in humans. Even though tubularized grafts
have not shown to be a preferential form of substitu-
tion, it avoids multi-stage surgery of ventral and dorsal
onlay urethroplasty. Whether everted SVG can be used
for tubularized urethraplasty remains unkown. us, we
performed anterior urethral reconstruction in a beagle
model using everted SVG in the tubular form.
Methods
Urethroplasty using everted SVG
is experimental animal protocol was approved by the
Animal Experimentation Ethics Committee of Wannan
Medical College in accordance with the Guide for the
Care and Use of Laboratory Animals. Twelve male bea-
gle dogs (Animal Research Center of Wannan Medical
College. Wuhu, China) weighing 8–10kg were randomly
divided into three groups: experimental group (n = 5),
control group (n = 5) and normal group (n = 2).
After general anesthesia with 3% pentobarbital, the
beagles in the experimental group and control group
were placed on an operating table in supine position. e
right thigh and genital organ were shaved and prepared
with povidone-iodine solution. A 4-cm incision was per-
formed on the ventral skin of penis. A 3cm segment of
anterior urethra was removed between the external ure-
thral orifice and bulbar urethra, in order to make a ure-
thral defect (Fig.1a).
A 4-cm incision was carried out on the right thigh skin
and a 3-cm SVG was excised (Fig. 1b). In the experi-
mental group, the vein grafts were everted like taking off
sleeves,without longitudinally cutting the venous wall,
(in order to make the endothelium outside) (Fig.1c). A
8 F catheter was inserted into the urethra and was used
as a stent (Fig.1d). Urethral defect was repaired by the
everted SVG in tubular fashion with 6–0 vicryl separated
sutures (Fig.1e). In the control group, the urethral defect
was repaired using uneverted SVG in the same fashion.
Nonabsorbable sutures were placed at the anastomosis
margins for mark. Muscular tissue around the recon-
structed urethra and the skin incision in penis was closed
in layers (Fig.1f). In the normal group, no surgical inter-
vention was performed. e procedures for all animals
were performed under sterile conditions by the same
surgeon.
Fig. 1 Anterior urethral reconstruction with SVG. a A segment of anterior urethra was separated. b A 3-cm SVG was harvested. c The SVG was
everted in experimental group. d The urethral catheter was inserted as a stent. e The urethral defect was repaired by SVG in tubular fashion. f The
subdermal layer in penis and the skin was closed
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Page 3 of 6
Lietal. BMC Urol (2021) 21:63
Postoperative care
An Elizabetan collar was placed around the neck of ani-
mal to prevent the catheter removal. e catheter was left
indwelling for two weeks. All animals in the experimental
group and control group received penicillin 100U/kg/day
intramuscularly for 14days.
Retrograde urethrography
Retrograde urethrography was performed every month
after operation. After general anesthesia, the animals
were placed obliquely on an examination table. A Foley
(6-F) catheter was inserted into the urethra until the
balloon entered the urethral orifice. Inflate the balloon
with 1ml sterilized water. X-ray images of urethra were
obtained under the fluoroscopy after contrast agent was
gently injected through the catheter.
Histological andimmunohistochemical analysis
Animals were euthanized by an overdose of 3% pento-
barbital and air embolization 6 months after opera-
tion. e penises were obtained and the segments of
the reconstructed urethra were extracted within the
area outlined by the marking sutures. ese segments
were placed in 10% formalin, dehydrated in graded alco-
hols, and then embedded in paraffin. Sections (5mm)
were cut and then stained with hematoxylin–eosin
(HE) staining, Masson’s trichrome(MT) staining, and
immunohistochemical(IHC) staining using CD-31 and
uroplakin-II(UP-II) antibodies.
IHC staining using CD-31 antibody were quantified to
compare neovascularization of the grafts using ImageJ
software, in 10 different fields for each tissue sample.
Data for these measurements are shown as mean ± SD.
Statistical analysis was performed using a t-test through
SPSS®, with p < 0.05 was considered as statistically
significant.
Radiologists and pathologists were blinded to the group
when they were evaluating.
Results
e surgical procedures were successfully performed on
all beagles. ere were no major intraoperative compli-
cations observed. During the 6months follow-up period,
four beagles in the experimental group showed no void-
ing difficulty and the other one could not spontaneously
void. Two beagles in control group could not sponta-
neously void and they underwent cystostomy with a
suprapubic catheter. Urogenic cutaneous fistula in penis
was detected in the other three animals in control group.
Retrograde urethrography
e retrograde urethrograms showed the urethral caliber
of four beagles in the experimental group were similar
to that of normal beagles (Fig.2a, b). e contrast agent
freely passed through the urethra without any signs of
stricture or contrast leak. ese indicate that the four
beagles in the experimental group maintained wide ure-
thral lumen 6 months postoperatively. e one beagle
in the experimental group could not void spontaneously
developed urethral stenosis. Ether significant urethral
stricture or fistula were detected in all animals in control
group (Fig.2c, d).
Histological andIHC examination
In the experimental group, HE staining indicated the ure-
thral lumen of the reconstructed segment was completely
covered by the urothelium (Fig.3e). ere was no obvi-
ous difference observed in the normal urethra (Fig.3a).
MT staining showed highly organized collagen fibers and
muscle tissue in the reconstructed urethra, but the mus-
cle tissue seemed to be less than what was present in the
normal urethra (Fig.3b, f). e UP-II antibody is a spe-
cial urothelium marker. IHC staining with UP-II antibody
showed positive expression in the urethral inner wall
(Fig.3g).
In the control group, the reconstructed segment
showed a narrow urethral lumen and the urothelium was
not intact (Fig.3i). MT staining showed abundant colla-
gen with strong blue staining, indicating severe fibrosis
Fig. 2 Retrograde urethrography. a Urethrogram in beagle in normal group. b Urethrogram in experimental group 6 months postoperatively. c
Urethral fistula in control group (red arrow point to the contrast leak). d Urethral stricture in control group (red arrow point to the stricture)
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Page 4 of 6
Lietal. BMC Urol (2021) 21:63
6 months postoperatively (Fig. 3j). IHC staining with
UP-II antibody revealed a fragment of urothelium in the
urethral inner wall (Fig.3k).
IHC staining using a CD31 antibody was performed to
observe the neovascularization of implanted tissue. In the
experimental group, IHC staining with a CD31 antibody
showed newly formed dense capillaries after 6months
(Fig.3h). In the control group, IHC staining using a CD31
antibody indicated sparse vascular capillaries (Fig. 3l).
Histomorphometric analysis found that the number of
newly formed capillaries in the experimental group was
higher than the control group (56.90 ± 1.57 vessels/mm2
vs 40.30 ± 1.06vessels/mm2, p < 0.01) (Fig.4).
Discussion
Various urethral conditions often require substitute ure-
thral reconstruction including long-segment urethral
strictures, traumatic defects, complicated hypospadias
and previous failed urethroplasty [9]. Several substituted
materials have been adopted for clinical urethroplasty,
including full-thickness skin graft, bladder mucosa, oral
mucosa (buccal or lingual mucosa) and colonic mucosa
[10–12]. Buccal mucosa and preputial skin graft remain
the widely used tissues for urethral replacement. How-
ever, there are associated complications, such as graft
necrosis, hair growth, stricture recurrence, and fis-
tula formation [13, 14]. In addition, harvesting buccal
mucosa may also lead to possible morbidities such as
intraoperative hemorrhage, submucosal scarring, pain,
postoperative infection, and injury to salivary ducts [3,
15]. Wood etal. [16] reported the morbidity of buccal
mucosa grafts harvested for urethroplasty in 57 patients.
Of these patients, 68% had perioral numbness that per-
sisted after 6months in 26% of the patients, 83% devel-
oped postoperative pain, 67% initially had difficulty with
mouth opening that persisted after 6months in 9% of the
Fig. 3 Histological and IHC analysis. a–d HE staining, MT staining, IHC staining with UP-II and CD31 antibodies of the reconstructed urethra in
normal group. e Wide urethral lumen was completely covered by endothelium in experimental group. f MT staining showed highly organized
collagen fibers and muscle tissue in subepithelium. g IHC staining with UP-II antibody showed expression of uroplakin in the endothelium. h IHC
staining with the CD31 showed dense capillaries in subepithelium. i HE staining showed a narrow urethral lumen and urothelium defect in control
group. j MT staining showed fibrosis with abundant collagen. k IHC staining with the UP-II revealed a fragment of urothelium. l Vascular capillaries
were sparse in control group
Fig. 4 Histomorphometric analysis of the extent of CD31 + vessels
present in the 3 groups. ※Signifificant difference among the
experimental and control groups (P < .01)
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Page 5 of 6
Lietal. BMC Urol (2021) 21:63
patients, and 2% had a mucous retention cyst. When ure-
thral defects are complex, donor tissue extracted from
oral cavity or prepuce may be insufficient. For these rea-
sons, many attempts have been made to select alternative
tissues that can serve as adequate urethral substitutes.
Tissue engineering may be a promising option for the
generation of an artificial urethra. However, accompa-
nied techniques are complex containing multi-steps and
the results of preliminary clinical applications are not sat-
isfactory [17, 18]. Up to now, tissue engineered urethra is
mainly being performed in animal experiments and has
not made its way to the clinic [19].
Tuffer et al. performed urethral reconstruction using
vein graft for the first time in 1910 [14]. Subsequently,
several animal trials have been reported using vein grafts
for urethral reconstruction [20–22]. Kahveci et al. [20]
suggested that a vein graft mainly acts as a scaffold and
the endothelium sloughs off after 3days. Hubner etal.
[22] and Foroutan et al. [23] used everted vein grafts
and showed improved outcomes. ey believed their
modified technique eliminated negative effects on urine
stream from the valve inside the venous lumen. We pre-
viously performed urethroplasty in a rabbit model with
saphenous vein patch as onlay graft and gained encour-
aging results [8]. Results of everted vs non-everted vein
grafts showed more optimal results with the everted
graft.
To the best of our knowledge, one of the key factors
in reconstructing urethra is adequate blood supply and
fast neovascularization of the implanted graft [24, 25].
Insufficient blood supply inevitably results in shrinkage
of grafts and the formation of fibrosis. In the study, the
saphenous vein was everted and the vascular endothe-
lium became outside. We hypothesized that everting the
vein graft making the vascular endothelium on the out-
side facilitates the everted SVG blood supply gain from
surrounding periurethral tissues including dartos. In this
study, IHC staining with CD31 antibody showed dense
vascular capillaries in the experimental group. Histomor-
phometric analysis demonstrated that compared to non-
everted SVG, everting the vein graft improved its ability
of neovascularization.
ere is a lack of studies investigating one-stage
reconstruction using a tubularized graft. Even though
tubularized grafts have not proven to be a preferential
substitution, they avoid multi-stage surgery of ventral
combined dorsal onlay urethroplasty. e saphenous
vein is a hollow tubular structure with a similar diam-
eter of the urethra. e saphenous vein is readily acces-
sible, even for the most extensive urethral reconstruction.
Adult male beagles were selected as our experimental
model because the urinary tract in beagle resemble the
urinary tract in human. Foroutan etal. [23] performed
histological study after euthanizing rabbits 7, 10, 14,
22, and 30days after operation, they found that gradual
uroepithelialization occurred within one month and
demonstrated that the vein graft functioned as a guide
for uroepithelium migration. e histological examina-
tion in our previous experiment revealed similar results
[8]. e everted vein graft showed full integration in the
neourethra. Urethral lumen was completely covered by
regenerative uroepithelium 6 months postoperatively.
Fistula formation and stenosis at the anastomosis were
noted in the animals of control group. e experimental
group showed improvement over the control group both
in retrograde urethrography and histologic analysis. e
MT staining showed that well-formed collagen and mus-
cle fibers in the experimental group. However, abundant
collagen fiber, narrow urethral lumen and urothelium
defect were observed in control group. e rapid survival
of the implant graft contributed to its function, serving
as a barrier against urine extravasation, as well as facili-
tating urothelium cell migration and proliferation in the
newly formed urethral tissue [26].
In this study, we create urethral defect models in the
healthy urethra of normal animals and cannot fully
resemble the exact clinical situation of urethral stricture
in humans, which is characterized by the fibrotic urethra
bed. Other limitations of this study includeasmallsam-
ple size and a short follow-up time. Further investiga-
tions with longer follow-up time are necessary to assess
its technical applicability and to translate this technology
into clinic.
Conclusion
We first used the everted SVG for tubularized urethral
reconstruction in a beagle model. In our study, 80% of
the experimental beagles showed no voiding difficulty
or urethral fistula. e animals showed wide urethral
lumen during the observation period. Everted SVG dem-
onstrates promise for anterior urethral stricture repair.
is study provides preclinical evidence and information
needed to move toward clinical studies of this technique.
Abbreviations
SVG: Saphenous vein graft; HE: Hematoxylin–eosin; MT: Masson’s trichrome;
IHC: Immunohistochemical; UP-II: Uroplakin-II.
Acknowledgements
Not applicable
Authors’ contributions
Protocol/project development: YX. Data collection or management: DL, ZS.
Manuscript writing/editing: YX, DL. All Authors read and approved the final
manuscript.
Funding
No funding or support received for this work.
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Page 6 of 6
Lietal. BMC Urol (2021) 21:63
•
fast, convenient online submission
•
thorough peer review by experienced researchers in your field
•
rapid publication on acceptance
•
support for research data, including large and complex data types
•
gold Open Access which fosters wider collaboration and increased citations
maximum visibility for your research: over 100M website views per year
•
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research
Ready to submit your research
? Choose BMC and benefit from:
? Choose BMC and benefit from:
Availability of data and materials
The datasets used and/or analysed during the current study available from the
corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
The beagles in this research were acquired from the Animal Research Center
of Wannan Medical College. Ethics approval was taken from Animal Experi-
mentation Ethics committee of Wannan Medical College in accordance with
the ARRIVE guidelines for reporting animal research.
Consent for publication
Not applicable.
Competing interests
The authors report no conflicts of interest.
Author details
1 Department of General Practice, The First Affiliated Hospital of Wannan
Medical College (Yijishan Hospital of Wannan Medical College), Wuhu 241000,
China. 2 Department of Urology, Anhui Provincial Hospital, Anhui Medical
University, Hefei, Anhui, China. 3 Department of Urology, The First Affiliated
Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical Col-
lege), 2 Zheshan West Road, Wuhu 241000, Anhui Province, China.
Received: 12 September 2020 Accepted: 12 April 2021
References
1. Barbagli G, Palminteri E, Lazzeri M, Guazzoni G. Anterior urethral strictures.
BJU Int. 2003;92(5):497–505.
2. Engel O, Fisch M. Urethral reconstruction after failed primary surgery.
Urologe A. 2010;49(7):822–6.
3. Bhargava S, Chapple CR. Buccal mucosal urethroplasty: is it the new gold
standard? BJU Int. 2004;93(9):1191–3.
4. Lee OT, Durbin-Johnson B, Kurzrock EA. Predictors of secondary surgery
after hypospadias repair: a population based analysis of 5,000 patients. J
Urol. 2013;190(1):251–5.
5. Sinha RJ, Singh V, Sankhwar SN, Dalela D. Donor site morbidity in oral
mucosa graft urethroplasty: implications of tobacco consumption. BMC
Urol. 2009;9:15.
6. Soave A, Dahlem R, Pinnschmidt HO, et al. Substitution urethroplasty with
closure versus nonclosure of the buccal mucosa graft harvest site: a rand-
omized controlled trial with a detailed analysis of oral pain and morbidity.
Eur Urol. 2018;73(6):910–22.
7. Dick F, Hristic A, Roost-Krähenbühl E, et al. Persistent sensitivity disorders
at the radial artery and saphenous vein graft harvest sites: a neglected
side effect of coronary artery bypass grafting procedures. Eur J Cardio-
thorac Surg. 2011;40(1):221–6.
8. Xu Y, Shen Z, Liu G, et al. Urethral reconstruction using everted SVG in a
rabbit model: one-year outcomes. Urol Int. 2017;99(1):110–7.
9. Peterson AC, Webster GD. Management of urethral stricture disease:
developing options for surgical intervention. BJU Int. 2004;94(7):971–6.
10. Liu JS, Han J, Said M, et al. Long-term outcomes of urethroplasty with
abdominal wall skin grafts. Urology. 2015;85(1):258–62.
11. O’Riordan A, Narahari R, Kumar V, Pickard R. Outcome of dorsal buccal
graft urethroplasty for recurrent bulbar urethral strictures. BJU Int.
2008;102(9):1148–51.
12. Xu Y-M, Qiao Y, Sa Y-L, Zhang J, Fu Q, Song L-J. Urethral reconstruc-
tion using colonic mucosa graft for complex strictures. J Urol.
2009;182(3):1040–3.
13. Brannan W, Ochsner MG, Fuselier HA, Goodlet JS. Free full thickness skin
graft urethroplasty for urethral stricture: experience with 66 patients. J
Urol. 1976;115(6):677–80.
14. Vyas PR, Roth DR, Perlmutter AD. Experience with free grafts in urethral
reconstruction. J Urol. 1987;137(3):471–4.
15. Rao AR, Shergill I, Thwaini A, Karim O, Motiwala H. Oral complications after
buccal mucosal graft harvest for urethroplasty. BJU Int. 2005;95(4):679.
16. Wood DN, Allen SE, Andrich DE, Greenwell TJ, Mundy AR. The morbid-
ity of buccal mucosal graft harvest for urethroplasty and the effect
of nonclosure of the graft harvest site on postoperative pain. J Urol.
2004;172(2):580–3.
17. Mangera A, Chapple CR. Tissue engineering in urethral reconstruction—
an update. Asian J Androl. 2013;15(1):89–92.
18. Dorin RP, Pohl HG, De Filippo RE, Yoo JJ, Atala A. Tubularized urethral
replacement with unseeded matrices: what is the maximum distance for
normal tissue regeneration? World J Urol. 2008;26(4):323–6.
19. Osman NI, Hillar y C, Bullock AJ, MacNeil S, Chapple CR. Tissue engineered
buccal mucosa for urethroplasty: progress and future directions. Adv
Drug Deliv Rev. 2015;82–83:69–76.
20. Kahveci R, Kahveci Z, Sirmali S, Ozcan M. Urethral reconstruction
with autologous vein graft: an experimental study. Br J Plast Surg.
1995;48(7):500–3.
21. Kim BS, Kim HT, Kwon SY, et al. Nontransected ventral onlay-augmented
urethroplasty using autologous SVG in a rabbit model of urethral stric-
ture. Urology. 2014;83(1):225–31.
22. Hübner W, Rurka I, Porpaczy P, Miko I. Autologous everted vein graft for
repairing long-section urethral defects. Urol Res. 1991;19(2):131–4.
23. Foroutan HR, Khalili A, Geramizadeh B, Rasekhi AR, Tanideh N. Urethral
reconstruction using autologous and everted vein graft: an experimental
study. Pediatr Surg Int. 2006;22(3):259–62.
24. Jia W, Tang H, Wu J, et al. Urethral tissue regeneration using collagen scaf-
fold modified with collagen binding VEGF in a beagle model. Biomateri-
als. 2015;69:45–55.
25. Niu Y, Liu G, Chen C, et al. Urethral reconstruction using an amphiphilic
tissue-engineered autologous polyurethane nanofiber scaffold with
rapid vascularization function. Biomater Sci. 2020;8(8):2164–74.
26. Orabi H, AbouShwareb T, Zhang Y, Yoo JJ, Atala A. Cell-seeded tubularized
scaffolds for reconstruction of long urethral defects: a preclinical study.
Eur Urol. 2013;63(3):531–8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com